NCT01736228 Open-label Investigation of the Safety and Efficacy of DIABECELL in Patients With Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT01726829 Overnight Type 1 Diabetes Control Under MD-Logic Closed Loop System at the Patient's Home Status COMPLETED Phase NA
NCT01724190 Effect of Vitamin D on the Honeymoon Period in Children and Adolescents With Type 1 Diabetes Status COMPLETED Phase NA
NCT01722682 Bone Marrow vs Liver as Site for Islet Transplantation Status COMPLETED Phase PHASE1/PHASE2
NCT01722643 Incentives, Cognitive Training and Internet Therapy for Teens With Poorly Controlled Type 1 Diabetes Status COMPLETED Phase NA
NCT01722227 Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes Status WITHDRAWN Phase PHASE3
NCT01718093 A Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 Diabetes Status COMPLETED Phase PHASE4
NCT01714895 Effect of Different Plasma Insulin Levels on the Accuracy of Continuous Subcutaneous Glucose Monitoring Status COMPLETED Phase NA
NCT01712594 Safety and Effectiveness Study of a Closed Loop System Maintaining Patients' Glucose Levels During an Overnight Period Status COMPLETED Phase NA
NCT01709851 Performance Study to Test the GlucoMen®Day System Using Intravascular and Subcutaneous Microdialysis in Subjects With Type 1 Diabetes Status COMPLETED Phase N/A
NCT01708044 Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM Status COMPLETED Phase PHASE1
NCT01697228 The Effects of Vitamin D on Glycemic Control and Proinflammatory Markers in Adolescents With T1DM Status COMPLETED Phase NA
NCT01693302 Timing of Meal Insulin Boluses for Optimal Postprandial Glycemic Control in Type 1 Diabetes Status COMPLETED Phase NA
NCT01691287 MICHAEL Method- Fulfilling Individual Potential to Attain Excellence - as a Tool for Improving Metabolic Control and Quality of Life Among Adolescence With Type 1 Diabetes Status COMPLETED Phase NA
NCT01684956 Pharmacokinetic Comparison of Intradermal Versus Sub-cutaneous Insulin and Glucagon Delivery in Type 1 Diabetes Status UNKNOWN Phase PHASE2